Orchid
PrivateLast Round
Series A
Dec 5, 2023
Total Funding Raised
$16.5M
Company Overview
Orchid operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in December 2023.
Orchid is a biotechnology company that provides whole-genome embryo screening services to help prospective parents identify and mitigate genetic risks during the IVF process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orchid Comparables
Compare Orchid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomic Prediction | 87% | |
| Luminary Life Sciences | 80% | |
| Nucleus Genomics | 78% |
For institutional investors. Book with your work email.
Orchid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 5, 2023 | ||||
| Seed | Apr 7, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orchid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Series A, Seed |
| Olive Capital | Seed |
| Starbloom Capital | Series A |
| Conviction | Series A |
| Boom Capital | Seed |
| Prometheus Fund | Series A |
| Village Global | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2023
$12M round led by Prometheus Fund.
- Apr 7, 2021
$4.5M raised from Village Global and Worklife Ventures.
For institutional investors. Book with your work email.
Orchid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orchid's valuation, stock price, and market status.
Is Orchid a public or private company?
Orchid is a private company.
What is the current stock price of Orchid?
Orchid is a private company, so its shares have no public market price. Caplight tracks Orchid's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orchid worth (valuation)?
Valuation information for Orchid is not publicly available.
Can I buy Orchid stock?
Orchid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orchid's last funding round?
Orchid's most recent funding round was Series A on December 5, 2023.
Who are the main investors in Orchid?
Key investors in Orchid include Prometheus Fund.
Will Orchid IPO soon?
No public IPO plans have been announced for Orchid.
How can I track Orchid secondary market activity?
Caplight tracks bids, offers, and trades in Orchid's shares on secondary markets.